Ocean Biomedical Inc. (NASDAQ: OCEA) – An Incubator with Potential Treatments for Cancer, Malaria and Fibrosis – Initiating Coverage
Highlights This company, formed in 2019, and based out of Rhode Island, U.S., is a biopharma...
Read MoreHighlights This company, formed in 2019, and based out of Rhode Island, U.S., is a biopharma...
Read MoreHighlights Q1-2023 revenue was up 7% YoY, to $18M, driven by higher rents and occupancy rates,...
Read MoreHighlights This company reported record revenue (up 22% YoY) and EPS (up 31% YoY) in 2022. Revenue...
Read MoreHighlights In 2022, revenue fell 24% YoY to $7.1M, but beat our estimate by 8%. Revenue declined...
Read MoreHighlights Since our previous report in December 2022, shares of the Big Five are up 3% on...
Read More